94 related articles for article (PubMed ID: 8694361)
1. Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expression.
Honoré P; Chapman V; Buritova J; Besson JM
Anesthesiology; 1996 Jul; 85(1):150-60. PubMed ID: 8694361
[TBL] [Abstract][Full Text] [Related]
2. The contribution of NMDA receptor activation to spinal c-Fos expression in a model of inflammatory pain.
Chapman V; Honoré P; Buritova J; Besson JM
Br J Pharmacol; 1995 Sep; 116(1):1628-34. PubMed ID: 8564229
[TBL] [Abstract][Full Text] [Related]
3. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
Chapman V; Buritova J; Honoré P; Besson JM
J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM
Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847
[TBL] [Abstract][Full Text] [Related]
5. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
[TBL] [Abstract][Full Text] [Related]
6. Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat.
Honoré P; Buritova J; Besson JM
Br J Pharmacol; 1996 Jun; 118(3):671-80. PubMed ID: 8762093
[TBL] [Abstract][Full Text] [Related]
7. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat.
Le Guen S; Catheline G; Besson JM
Eur J Pharmacol; 1999 May; 373(1):1-11. PubMed ID: 10408246
[TBL] [Abstract][Full Text] [Related]
8. When is the maximal effect of pre-administered systemic morphine on carrageenin evoked spinal c-Fos expression in the rat?
Honoré P; Chapman V; Buritova J; Besson JM
Brain Res; 1995 Dec; 705(1-2):91-6. PubMed ID: 8821738
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with systemic morphine induced tolerance to the systemic and peripheral antinociceptive effects of morphine on both carrageenin induced mechanical hyperalgesia and spinal c-Fos expression in awake rats.
Honoré P; Catheline G; Le Guen S; Besson JM
Pain; 1997 May; 71(1):99-108. PubMed ID: 9200179
[TBL] [Abstract][Full Text] [Related]
10. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
11. Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammation.
Le Guen S; Catheline G; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
Brain Res; 2003 Mar; 967(1-2):106-12. PubMed ID: 12650971
[TBL] [Abstract][Full Text] [Related]
12. The effects of morphine on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist.
Honoré P; Buritova J; Besson JM
Brain Res; 1996 Sep; 732(1-2):242-6. PubMed ID: 8891291
[TBL] [Abstract][Full Text] [Related]
13. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
Honoré P; Chapman V; Buritova J; Besson JM
J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375
[TBL] [Abstract][Full Text] [Related]
14. Morphine and NMDA receptor antagonism reduce c-fos expression in spinal trigeminal nucleus produced by acute injury to the TMJ region.
Bereiter DA; Bereiter DF
Pain; 2000 Mar; 85(1-2):65-77. PubMed ID: 10692604
[TBL] [Abstract][Full Text] [Related]
15. Development of tolerance to the antinociceptive effect of systemic morphine at the lumbar spinal cord level: a c-Fos study in the rat.
Le Guen S; Catheline G; Besson JM
Brain Res; 1998 Nov; 813(1):128-38. PubMed ID: 9824685
[TBL] [Abstract][Full Text] [Related]
16. Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin.
Honoré P; Buritova J; Besson JM
Eur J Pharmacol; 1995 Jan; 272(2-3):249-59. PubMed ID: 7713169
[TBL] [Abstract][Full Text] [Related]
17. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Anesthesiology; 2000 Mar; 92(3):786-94. PubMed ID: 10719957
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the rat.
Chapman V; Honoré P; Buritova J; Besson JM
Neuroscience; 1995 Aug; 67(3):731-9. PubMed ID: 7675199
[TBL] [Abstract][Full Text] [Related]
19. Tolerance to morphine analgesia: evidence for stimulus intensity as a key factor and complete reversal by a glycine site-specific NMDA antagonist.
Adam F; Bonnet F; Le Bars D
Neuropharmacology; 2006 Aug; 51(2):191-202. PubMed ID: 16713606
[TBL] [Abstract][Full Text] [Related]
20. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats.
Martinez V; Christensen D; Kayser V
Pain; 2002 Oct; 99(3):537-545. PubMed ID: 12406530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]